Spectranetics
Colorado Springs, CO 80921
Share:
Spectranetics to Launch CLiRpath Turbo Product Line
COLORADO SPRINGS, Colo., Sept. 19/ -- Spectranetics Corporation (NASDAQ:SPNC) today announced it will extend features of the recently launched 2.5 Turbo product to its entire CLiRpath(R) product line used for clearing arterial blockages in the leg. Spectranetics has received 510(k) clearance from the Food and Drug Administration for the continuous on lasing train to be added to its entire...
Read More »Spectranetics to Present at The A.G Edwards Growth Conference on September 18
COLORADO SPRINGS, Colo., Sept. 11 / -- Spectranetics Corporation (NASDAQ:SPNC) today announced that it will present at the A.G. Edwards Growth Conference, which is being held September 18-19 at the New York Palace Hotel. John G. Schulte, Spectranetics' president and chief executive officer, is scheduled to speak on Tuesday, September 18, at 9:30 a.m. Eastern time (7:30 a.m. Mountain time) and...
Read More »Spectranetics Receives Clearance to Market TURBO elite Product Line
COLORADO SPRINGS, Colo., Oct. 4 /PRNewswire-FirstCall/ -- Spectranetics Corporation (NASDAQ:SPNC) announced today that it has received clearance from the Food and Drug Administration (FDA) to market its TURBO elite(TM) product line for the treatment of blockages within leg arteries. This new product line is designed for improved pushability, trackability and ablation capability as a result of an...
Read More »Spectranetics Initiates Research Collaboration to Combine Imaging Technology with its Laser Devices
COLORADO SPRINGS, Colo., May 18 / / -- Spectranetics Corporation (NASDAQ:SPNC) announced today that it has entered into a research collaboration with BioScan Technologies Ltd., a privately held Israeli company. The initial phase of the contract will focus on the feasibility of combining Spectranetics' fiber-optic laser catheters with the optical imaging technology of BioScan. If feasibility is...
Read More »Spectranetics to Launch CLiRpath Turbo Product Line
COLORADO SPRINGS, Colo., Sept. 19/ -- Spectranetics Corporation (NASDAQ:SPNC) today announced it will extend features of the recently launched 2.5 Turbo product to its entire CLiRpath(R) product line used for clearing arterial blockages in the leg. Spectranetics has received 510(k) clearance from the Food and Drug Administration for the continuous on lasing train to be added to its entire...
Read More »